AirSculpt Technologies, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from AirSculpt Technologies, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, equals 83% of its market value (net debt). Lower than 94% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $37 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 90% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
1.5×Over the last 3 years its own operating cash covered its investment spending (capex) 1.5 times.
Higher than 70% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 10%
Sales fell 10% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-10% / -7%In 3 years sales changed by -10% while total assets changed by -7%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
0.6×Debt due within a year is covered 0.6 times by its yearly operating cash.
Higher than 70% of Healthcare companies in United States.
Cash Cushion Ratio
−83%Debt, after subtracting cash, equals 83% of its market value (net debt).
Lower than 94% of Healthcare companies in United States.
Tangible Assets Ratio
37%Of every $100 the company owns, $37 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 90% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 84% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
AirSculpt Technologies, Inc. made a loss over the last year. AirSculpt Technologies, Inc. owes $0.46 for every $1 it owns. AirSculpt Technologies, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossAirSculpt Technologies, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.86The share price is 0.86 times AirSculpt Technologies, Inc.'s book value per share, lower than 82% of Healthcare companies in United States.
Market cap
$90 MThe total market value of all of AirSculpt Technologies, Inc.'s shares at today's price (share price × number of shares), smaller than 67% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$105 MWhat AirSculpt Technologies, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.45Net worth divided by the number of shares. The share price of $1.25 is 0.9 times this, which is the P/B above.
Return on equity (ROE)
-12.0%AirSculpt Technologies, Inc. lost 12.0% of its shareholders' money over the last year, higher than 70% of Healthcare companies in United States.
Owes vs Owns
0.46×AirSculpt Technologies, Inc. owes $0.46 for every $1 it owns (low), higher than 52% of Healthcare companies in United States.
Dividend yield
NoneAirSculpt Technologies, Inc. does not currently pay a dividend.
Revenue growth
-16%Revenue fell 16% in the year to Dec 2025, and shrank 3% a year on average over 3 years.
Profit growth
LossAirSculpt Technologies, Inc. made a loss in each of the last two years.
Profit margin
-7.7%AirSculpt Technologies, Inc. lost $8 for every $100 of revenue.
Interest cover
Not coveredAirSculpt Technologies, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtAirSculpt Technologies, Inc. had $75 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For AirSculpt Technologies, Inc.: $90 M ÷ $105 M (30 Jun 2026) = 0.9.
What is AirSculpt Technologies, Inc.'s return on equity?
AirSculpt Technologies, Inc. lost 12.0% of its shareholders' money over the last year, higher than 70% of Healthcare companies in United States.
How much does AirSculpt Technologies, Inc. owe compared with what it owns?
AirSculpt Technologies, Inc. owes $0.46 for every $1 it owns (low), higher than 52% of Healthcare companies in United States.
Does AirSculpt Technologies, Inc. pay a dividend?
No. AirSculpt Technologies, Inc. does not currently pay a dividend.
Is AirSculpt Technologies, Inc.'s revenue growing?
Revenue fell 16% in the year to Dec 2025, and shrank 3% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.